Henrietta Lacks: Family Secures Second Major Settlement Over 'Stolen Cells'

Henrietta Lacks: Family of 'Stolen Cells' Woman Settle Second Lawsuit

In a landmark development, the family of Henrietta Lacks, whose cervical cells were harvested without her knowledge in 1951 and have since been replicated endlessly, has achieved a significant settlement with a second major biotech company. This marks another step forward in their decades-long pursuit of justice and recognition.

Justice Sought from Novartis

The latest agreement involves Switzerland-based pharmaceutical giant Novartis. The company faced a lawsuit alleging it profited extensively from Ms. Lacks's extraordinary cells, which were obtained without consent but have been instrumental in countless medical breakthroughs worldwide. For years, Ms. Lacks's descendants have advocated tirelessly for compensation and acknowledgment of this profound injustice.

This settlement follows a similar resolution nearly three years ago, when the family reached undisclosed terms with Massachusetts-based Thermo Fisher Scientific Inc., another prominent biotech firm.

The Story of Henrietta Lacks and the Immortal HeLa Cells

Henrietta Lacks, a 31-year-old mother residing in Baltimore, Maryland, sought medical attention in 1951 for abdominal pain and unusual bleeding. Examinations by gynecologists at Johns Hopkins Hospital revealed a large, aggressive mass on her cervix.

Crucially, without her knowledge or explicit permission, doctors took a sample of her tumor for laboratory research before initiating treatment for her aggressive cervical cancer. What happened next was unprecedented in scientific history.

While most human cell cultures quickly perished in the lab, the cells taken from Ms. Lacks exhibited an extraordinary ability to multiply indefinitely and resist the aging process, earning them the moniker "immortal." This unique characteristic meant that scientists globally could conduct replicated experiments using a consistent and identical cell line.

HeLa Cells: A Scientific Miracle Born from Injustice

The unprecedented cell line, named "HeLa" after Henrietta Lacks's first two initials, was rapidly distributed to research facilities across the globe. According to the World Health Organization (WHO), HeLa cells have been fundamental to some of the most profound medical advancements, including the development of the polio vaccine and crucial progress in HIV, cancer, and infertility research.

However, the very properties that made these cells a scientific marvel also underscored a tragic irony for Henrietta. Just months after her diagnosis, Ms. Lacks succumbed to cancer at the young age of 31, leaving behind a profound legacy buried in an unmarked grave.

A Family's Enduring Fight for Dignity and Compensation

Seventy years after her passing, Henrietta Lacks's family initiated legal action against Novartis in Maryland. Several other lawsuits against various pharmaceutical companies are reportedly still in progress, reflecting the vast and ongoing impact of the HeLa cells.

While the specific details of the recent settlement with Novartis remain confidential, a joint statement from the family and Novartis expressed satisfaction: "Members of the family of Henrietta Lacks and Novartis are pleased they were able to find a way to resolve this matter filed by Henrietta Lacks's estate outside of court."

Attorney Ben Crump, representing the Lacks family, conveyed their contentment with the outcome to the New York Times. He emphasized the significance of this moment for the family and Ms. Lacks's grandchildren, stating, "For the family and her grandchildren, this is certainly justice because people said they would never realise any benefit or compensation from her immortal HeLa cells, even though these pharmaceutical companies were profiting billions and billions of dollars."

Crump further characterized the agreement as providing "some measure of justice, to offer respect and dignity to the life that was taken," underscoring the profound human aspect of this historic legal battle.